Is Eli Lilly using ‘granfluencers’ to raise awareness of its Alzheimer’s med?
By
Marc Iskowitz
Sep 04, 2024
Here’s why older internet celebs — granfluencers — soon might be making rounds on the Alzheimer’s drug marketing scene.
Timing of blood pressure meds has no impact on outcomes
By
Haymarket Media
Sep 10, 2024
The findings were seen for both primary care patients with hypertension and nursing home residents.
SGLT-2 inhibitors may cut dementia risk in patients with diabetes
By
Haymarket Media
Sep 03, 2024
The findings show a greater effect with longer treatment, compared with dipeptidyl peptidase-4 inhibitors.
Cholinesterase inhibitors beneficial for dementia with Lewy bodies
By
Haymarket Media
Aug 28, 2024
The use of cholinesterase inhibitors significantly slowed cognitive decline at follow-ups compared with memantine and nonuse.
No spike in schizophrenia, other diagnoses among people with dementia after feds crack down on antipsychotic...
By
Kimberly Marselas
Aug 28, 2024
Federal policies designed to reduce use of antipsychotic medications in nursing homes did not lead to clinically significantly higher rates of schizophrenia diagnoses among people living with dementia,...
New deals will cut Medicare costs for expensive drugs
Aug 15, 2024
The Biden administration said Thursday that it has signed deals with drug companies that will lower the prices on 10 of the most popular and expensive drugs used by American seniors.
Commonly prescribed antibiotics linked to cutaneous adverse drug reactions
Aug 12, 2024
Sulfonamide antibiotics and cephalosporins are most strongly associated with serious cADRs relative to macrolides.
Pandemic challenges raise concerns about assisted living’s ability to care for cognitively impaired...
By
Kimberly Bonvissuto
Aug 15, 2024
Exacerbated challenges faced by memory care assisted living communities during the COVID-19 pandemic may have contributed to the increased use of antipsychotics and antidepressants, raising concerns about...
PREVENT equations reclassify half of US adults to lower ASCVD risk
Aug 02, 2024
A considerable decrease was estimated in US adults receiving or recommended for preventive treatment with statins and antihypertensives.
Semaglutide seems beneficial for comorbid T2DM, tobacco use disorder
Jul 29, 2024
A lower risk for medical encounters for a tobacco use disorder diagnosis was seen in association with semaglutide versus other antidiabetes meds.